annb0t
Top 20
Opthea Limited
MELBOURNE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr. Megan Baldwin, the Companyâs Chief Executive Officer will present at the Sequire Biotechnology Conference being held virtually on February 2, 2023.
Dr. Baldwin will present on Thursday, February 2nd at 10:00 am ET (2:00 am AEDT)....
>>> Read more: Opthea To Present at Sequire Biotechnology Conference
MELBOURNE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr. Megan Baldwin, the Companyâs Chief Executive Officer will present at the Sequire Biotechnology Conference being held virtually on February 2, 2023.
Dr. Baldwin will present on Thursday, February 2nd at 10:00 am ET (2:00 am AEDT)....
>>> Read more: Opthea To Present at Sequire Biotechnology Conference
